Literature DB >> 3133341

Oxic and hypoxic cells in a murine squamous cell carcinoma.

Y Takai1, K Sakamoto, S Okada.   

Abstract

[125I]Iododeoxyuridine labeling of a squamous cell carcinoma and follow-up of 125I activity at the tumor in situ revealed that the 125I activity remained at a constant level from the 24th to the 100th hour post-labeling and then decreased with a half time of about 200 hr. Autoradiographic studies with [3H]thymidine showed that the tumor cells were labeled around capillaries, spread through the corded structure (the cord) and finally reached the necrotic regions. One could speculate that the constant 125I period represents the transit time of the labeled cells through the cord and that the decline occurs mostly in the necrotic regions. X-Irradiation shortened the constant period of 125I activity by about 24 hr and accelerated the declining rate in a dose-dependent manner. When tumors were made hypoxic by clamping the legs, the declining rate decreased significantly. When misonidazole (a hypoxic radiosensitizer) was administered before X-rays, the declining rate increased to a level higher than that of the oxic tumors. From the time course studies, it was suggested that the tumor cells immediately after 125I-labeling were oxic, that they became gradually hypoxic during their transit through the cord and that they became anoxic when they reached the necrotic regions.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3133341      PMCID: PMC5917502          DOI: 10.1111/j.1349-7006.1988.tb01622.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


[123I]iododeoxyuridine
  10 in total

1.  In vivo assay of the radiation sensitivity of hypoxic tumour cells; influence of gamma-rays cyclotron neutrons, misonidazole, hyperthermia and mixed modalities.

Authors:  W Porschen; J Gartzen; K Geweher; H Mühlensiepen; H J Weber; L E Feinedegen
Journal:  Br J Cancer Suppl       Date:  1978-06

2.  An evaluation of radioiodine-labeled 5-iodo-2'-deoxyuridine as a tracer for measuring cell loss from solid tumors.

Authors:  L A Dethlefsen
Journal:  Cell Tissue Kinet       Date:  1971-03

3.  Survival curves for clonogenic cells of a murine keratinizing squamous carcinoma irradiated in vivo or under hypoxic conditions.

Authors:  H B Hewitt; D P Chan; E R Blake
Journal:  Int J Radiat Biol Relat Stud Phys Chem Med       Date:  1967

4.  [In-vivo-examinations of the relative radiosensitivity of hypoxic tumor cells (author's transl)].

Authors:  P Bosiljanoff; W Porschen; W Piepenbring; H Mühlensiepen; L E Feinendegen
Journal:  Strahlentherapie       Date:  1977-03

5.  Radiation sensitivity of DNA molecules in situ in normal and neoplastic tissues of mice.

Authors:  T Ono; K Sakamoto; S Okada
Journal:  Acta Radiol Oncol       Date:  1980

6.  Cell loss from several types of solid murine tumour: comparison of 125I-iododeoxyuridine and tritiated thymidine methods.

Authors:  A C Begg
Journal:  Cell Tissue Kinet       Date:  1977-09

7.  Reutilization of 131I-5-iodo-2'-deoxyuridine as compared to 3H-thymidine in mouse duodenum and mammary tumor.

Authors:  L A Dethlefsen
Journal:  J Natl Cancer Inst       Date:  1970-04       Impact factor: 13.506

8.  Cell loss from viable and necrotic tumour regions measured by 125I-UdR.

Authors:  R Porschen; W Porschen; H Mühlensiepen; L E Feinendegen
Journal:  Cell Tissue Kinet       Date:  1983-11

9.  The comparative survival of clonogenic cells of a murine epithelioma after irradiation in mice breathing air, oxygen and carbon dioxide, or hyperbaric oxygen.

Authors:  H B Hewitt; K Sakamoto
Journal:  Br J Radiol       Date:  1971-06       Impact factor: 3.039

10.  The histological structure of some human lung cancers and the possible implications for radiotherapy.

Authors:  R H THOMLINSON; L H GRAY
Journal:  Br J Cancer       Date:  1955-12       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.